Nafcillin for Injection recalled over sterility concerns
- Recall date
- May 19, 2023
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Sagent Pharmaceuticals Inc recalls Nafcillin for Injection, USP, 2 gram per vial, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195. NDC: 250…
- Recall number
- D-0763-2023
- FDA classification
- Class II
- Brand / firm
- Sagent Pharmaceuticals Inc
- Sold / distributed
- Nationwide USA
Why it was recalled
Lack of Assurance of Sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Nafcillin for Injection, USP, 2 gram per vial, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195. NDC: 25021-140-10
Get recall alerts
Free email alert whenever Sagent Pharmaceuticals Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Sagent Pharmaceuticals Inc